Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yafu Wu"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveHepatocellular carcinoma (HCC) is a malignant tumor. The occurrence of HCC is involved in the alteration of a variety of oncogenes or tumor suppressor genes, but the specific molecular mechanism remains unknown. This research proved the effe
Externí odkaz:
https://doaj.org/article/cca04c51db974e1aa6cb32bd817ad203
Autor:
Song Liu, Ji Miao, Xiaolei Shi, Yafu Wu, Chunping Jiang, Xinhua Zhu, Xingyu Wu, Yitao Ding, Qingxiang Xu
Publikováno v:
Journal of Investigative Surgery, Vol 31, Iss 5, Pp 393-401 (2018)
Purpose: In spite of the increasing success of liver transplantation, there remains inevitable risk of postoperative complications, re-operations, and even death. Risk factors that correlate with post-transplant death have not been fully identified.
Externí odkaz:
https://doaj.org/article/b7626324a6f24c0d96496e004feff278
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality and poor prognosis. Long non-coding RNAs NEAT1 (lncRNA NEAT1) have been found to play an important role in HCC progression. However, the role and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a553dac44484da7a48a9751103b2414
https://doi.org/10.21203/rs.3.rs-1038606/v1
https://doi.org/10.21203/rs.3.rs-1038606/v1
Background: Sorafenib is one of the most commonly used systemic therapies for hepatocellular carcinoma (HCC), but the acquired resistance towards sorafenib found in HCC patients usually led to failure of treatment and poor prognosis. Therefore, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5c5b8535be17a3bae6bee17884b81589
https://europepmc.org/articles/PMC6949556/
https://europepmc.org/articles/PMC6949556/
Autor:
Wenxian Guan, Xitai Sun, Yitao Ding, Xiaolei Shi, Yafu Wu, Jianxin Zhou, Weiwei Zhang, Chunping Jiang, Yudong Qiu, Decai Yu, Xianwen Yuan
Publikováno v:
Oncology Reports. 34:823-832
Ubiquitin specific protease 39 (USP39) plays an important role in mRNA splicing. In the present study, we investigated the role of USP39 in regulating the growth of hepatocellular carcinoma (HCC). We detected USP39 expression in more than 100 HCC cli
Autor:
Xin-Hua Zhu, Qingxiang Xu, Xingyu Wu, Xiaolei Shi, Chunping Jiang, Yafu Wu, Song Liu, Ji Miao, Yitao Ding
Publikováno v:
Journal of investigative surgery : the official journal of the Academy of Surgical Research. 31(5)
In spite of the increasing success of liver transplantation, there remains inevitable risk of postoperative complications, re-operations, and even death. Risk factors that correlate with post-transplant death have not been fully identified.We perform
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 38:996-1002
BACKGROUND The efficacy and feeding-related complications of a nasojejunal feeding tube and jejunostomy after pancreaticoduodenectomy (PD) was investigated with a randomized, controlled clinical trial at the Affiliated Drum Tower Hospital. METHODS Si
Publikováno v:
Liver International. 30:611-622
Background: The availability of well-characterized human hepatocytes that can be frozen and thawed will be critical for cell therapy. We addressed whether human hepatocytes can recover after microencapsulated cryopreservation and investigated whether
Publikováno v:
Clinical Cancer Research. 13:3814-3824
Purpose: To investigate the distribution, frequency, and clinical significance of mobilized endothelial progenitor cells (EPC) in hepatocellular carcinoma (HCC). Experimental Design: In healthy controls and patients with HCC, the frequency of circula
Publikováno v:
Oncology Letters
Hilar cholangiocarcinoma is a highly malignant tumor and is currently treated by surgical resection or liver transplantation; however, these treatments result in poor patient prognosis accompanied with high recurrence and low patient mortality rates.